Jayesh Patel, MD | |
227 E Somerdale Rd, Somerdale, NJ 08083-1105 | |
(856) 784-2626 | |
(856) 784-0375 |
Full Name | Jayesh Patel |
---|---|
Gender | Male |
Speciality | Internal Medicine |
Experience | 29 Years |
Location | 227 E Somerdale Rd, Somerdale, New Jersey |
Accepts Medicare Assignments | Yes. He accepts the Medicare-approved amount; you will not be billed for any more than the Medicare deductible and coinsurance. |
Identifier | Type | State | Issuer |
---|---|---|---|
1932203171 | NPI | - | NPPES |
8572003 | Medicaid | NJ |
Taxonomy | Type | License (State) | Status |
---|---|---|---|
207R00000X | Internal Medicine | MA71893 (New Jersey) | Primary |
Facility Name | Location | Facility Type |
---|---|---|
Bayada Home Health Care, Inc | Cherry hill, NJ | Home health agency |
Virtua Home Care At West Jersey | Mount laurel, NJ | Home health agency |
Virtua West Jersey Hospitals | Voorhees, NJ | Hospital |
Cooper University Hospital | Camden, NJ | Hospital |
Entity Name | Primary Care Affiliates Of Nj, Pa |
---|---|
Entity Type | Part B Supplier - Clinic/group Practice |
Entity Identifiers | NPI Number: 1639260896 PECOS PAC ID: 2860396074 Enrollment ID: O20031120000399 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute describes a novel marker that might help doctors choose the least toxic, most effective treatment for many older patients with acute myeloid leukemia (AML).
Evolving patients' needs, limited number of medical specialists in remote areas, and technological advances are some of the most important factors driving interest in visual collaboration in healthcare.
NOXXON Pharma today announced the successful completion of patient recruitment of its NOX-E36 Phase IIa clinical trial for the treatment of diabetic nephropathy. NOX-E36 is a SpiegelmerĀ® that binds and neutralizes CCL2/MCP-1 (C-C Chemokine Ligand / Monocyte Chemoattractant Protein-1), a pro-inflammatory chemokine that plays an important role in the progression of diabetic nephropathy, the most common single cause of chronic kidney failure and end-stage renal disease.
Wake Forest University Baptist Medical Center will be one of the first medical centers in the region to begin using a new generation of drug-coated stents next week following a major study and the Food and Drug Administration's approval of their use.
› Verified 9 days ago
Mailing Address | Practice Location Address |
---|---|
Jayesh Patel, MD Po Box 40, Somerdale, NJ 08083-0040 Ph: (856) 784-2626 | Jayesh Patel, MD 227 E Somerdale Rd, Somerdale, NJ 08083-1105 Ph: (856) 784-2626 |
News Archive
A new study led by researchers at The Ohio State University Comprehensive Cancer Center - Arthur G. James Cancer Hospital and Richard J. Solove Research Institute describes a novel marker that might help doctors choose the least toxic, most effective treatment for many older patients with acute myeloid leukemia (AML).
Evolving patients' needs, limited number of medical specialists in remote areas, and technological advances are some of the most important factors driving interest in visual collaboration in healthcare.
NOXXON Pharma today announced the successful completion of patient recruitment of its NOX-E36 Phase IIa clinical trial for the treatment of diabetic nephropathy. NOX-E36 is a SpiegelmerĀ® that binds and neutralizes CCL2/MCP-1 (C-C Chemokine Ligand / Monocyte Chemoattractant Protein-1), a pro-inflammatory chemokine that plays an important role in the progression of diabetic nephropathy, the most common single cause of chronic kidney failure and end-stage renal disease.
Wake Forest University Baptist Medical Center will be one of the first medical centers in the region to begin using a new generation of drug-coated stents next week following a major study and the Food and Drug Administration's approval of their use.
› Verified 9 days ago
Dr. Vijay K Kalola, M.D. Internal Medicine Medicare: Accepting Medicare Assignments Practice Location: 300 S Warwick Rd, Somerdale, NJ 08083 Phone: 856-784-6666 |